SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-17-339881
Filing Date
2017-11-13
Accepted
2017-11-13 07:51:11
Documents
3
Group Members
ALLERGAN HOLDINGS B1, INC.ALLERGAN W.C. HOLDING INC.ALLERGAN WC HOLDINGS IRELAND LTD (FORMERLY KNOWN AS WARNER CHILCOTT PLC)WARNER CHILCOTT LTD

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d486332dsc13da.htm SC 13D/A 125383
2 EX-99.1 d486332dex991.htm EX-99.1 7575
3 EX-99.4 d486332dex994.htm EX-99.4 243843
  Complete submission text file 0001193125-17-339881.txt   378824
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267
TEVA PHARMACEUTICAL INDUSTRIES LTD (Subject) CIK: 0000818686 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-55457 | Film No.: 171193169
SIC: 2834 Pharmaceutical Preparations

Mailing Address CLONSHAUGH BUSINESS AND TECHNOLOGY PARK COOLOCK, DUBLIN L2 D17 E400
Business Address CLONSHAUGH BUSINESS AND TECHNOLOGY PARK COOLOCK, DUBLIN L2 D17 E400 (216) 523-5000
Allergan plc (Filed by) CIK: 0001578845 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 2834 Pharmaceutical Preparations